Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?

Background & objectives: There is a persistent high microfilaria rate and variable reporting of coverage of Mass Drug Administration (MDA). This study aims to estimate the coverage, effective coverage, and compliance of drugs administered under MDA and determine the predictors affecting effectiv...

Full description

Bibliographic Details
Published in:	Journal of Vector Borne Diseases
Main Authors:	Sourabh Paul, Aswani Kumar Seth, Neeraj Pawar, Abhay Singh, Mukesh Shukla, Bhola Nath
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-04-01
Subjects:	compliance effective coverage endemic lymphatic filariasis mass drug administration
Online Access:	https://journals.lww.com/10.4103/JVBD.JVBD_102_24

Similar Items

Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India
by: Abu Bashar, et al.
Published: (2023-01-01)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008-01-01)

Detection of anti-filarial antibody among hydrocele patients living in an endemic area for filariasis
by: Amit Kumar Singh, et al.
Published: (2016-01-01)

Chiluria in a lymphatic filariasis endemic area
by: Paulo Sérgio Ramos de Araújo, et al.
Published: (2018-05-01)

Coverage And Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Endemic Areas of Sagar and Damoh Districts, Madhya Pradesh
by: Arvind Sharma, et al.
Published: (2013-12-01)

Epidemiology of lymphatic filariasis with special reference to urogenital-manifestations
by: S P Pani, et al.
Published: (2005-01-01)

Keanekaragaman dan Dominasi Nyamuk di Daerah Endemis Filariasis Limfatik, Kota Pekalongan
by: Tri Ramadhani, et al.
Published: (2016-06-01)

POST MASS DRUG ADMINISTRATION ASSESSMENT OF COVERAGE, COMPLIANCE, AND OBSTACLES IN A LYMPHATIC FILARIASIS ENDEMIC DISTRICT OF CENTRAL INDIA.
by: Neelam Anupama Toppo, et al.
Published: (2023-03-01)

Evaluation Of Coverage and Compliance of Mass Drug Administration Programme 2011 For Elimination of Lymphatic Filariasis in Nalgonda District Of Andhra Pradesh, India
by: Abhay S Nirgude, et al.
Published: (2012-06-01)

Knowledge and practices on lymphatic filariasis in patients with filarial morbidity in an endemic area in Northeastern Brazil
by: Márcia Marcondes, et al.
Published: (2024-06-01)

Drug targets for lymphatic filariasis: A bioinformatics approach
by: Om Prakash Sharma, et al.
Published: (2013-08-01)

Lymphatic Filariasis in Brazilian Urban Area (Maceió, Alagoas)
by: Fontes Gilberto, et al.
Published: (1998-01-01)

Hydrocele fluid: Can it be used for immunodiagnosis of lymphatic filariasis?
by: S. Mishra, et al.
Published: (2014-08-01)

Incidentally Detected Lymphatic Filariasis in a Renal Allograft Recipient
by: AV Vanikar, et al.
Published: (2013-07-01)

Ghana’s path towards eliminating lymphatic filariasis
by: Munawar Harun Koray
Published: (2024-05-01)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
by: T S Ranganath, et al.
Published: (2012-01-01)

Lymphatic filariasis as an indigenous illness: the local context of a global disease
by: Jonathan Roberts, et al.
Published: (2025-12-01)

Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target
by: Michael Ofire Ofire, et al.
Published: (2025-03-01)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
by: Morgan E. Lemin, et al.
Published: (2022-10-01)

A Study on Coverage Evaluation, Compliance and Awareness of Mass Drug Administration for Elimination of Lymphatic Filariasis in Osmanabad District
by: Lata B Godale, et al.
Published: (2012-09-01)

Morbidity hotspot surveillance: A novel approach to detect lymphatic filariasis transmission in non-endemic areas of the Tillabéry region of Niger
by: Xavier Badia-Rius, et al.
Published: (2023-05-01)

Brazil was certified by the World Health Organization for having eliminated lymphatic filariasis: what now?
by: Eduardo Brandão, et al.
Published: (2025-03-01)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
by: Meru Sheel, et al.
Published: (2021-07-01)

Elimination of lymphatic filariasis: Where do we stand so far?
by: Aashna Sinha, et al.
Published: (2023-01-01)

An empirical analysis of the effects of schistosomiasis and lymphatic filariasis on macroeconomic output in Ghana
by: Mustapha Immurana, et al.
Published: (2024-05-01)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
by: Tile A. Ah Leong-Lui, et al.
Published: (2019-11-01)

The effects of variable spatial aggregation on lymphatic filariasis transmission
by: Callum Shaw, et al.
Published: (2025-01-01)

Sensitivity analysis and parameters estimation for the transmission of lymphatic filariasis
by: Mussa A. Stephano, et al.
Published: (2023-09-01)

Rapid progress towards elimination of lymphatic filariasis in endemic regions of Myanmar as a result of 16 years of anti-filarial activities (2001–2016)
by: Kyawt Mon Win, et al.
Published: (2018-04-01)

Information technology in morbidity management of human lymphatic filariasis—A promising tool in global programme for elimination of lymphatic filariasis
by: R Renuka Devi, et al.
Published: (2018-01-01)

Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme
by: A.K. Mukhopadhyay
Published: (2010-03-01)

Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August–September 2018
by: Vicent Mwesigye, et al.
Published: (2024-05-01)

A Review of Bed Nets Usage and Sewerage Conditions as Risk Factors for Lymphatic Filariasis in Developing Countries
by: Muhafasya Karunia Azzahra, et al.
Published: (2024-01-01)

Entomological assessment in ‘hotspots’ of four lymphatic filariasis endemic districts, Central Nepal during post-MDA surveillance
by: Pramod Kumar Mehta, et al.
Published: (2024-01-01)

Mass drug administration to eliminate lymphatic filariasis: A population-based coverage and compliance study in Eastern India
by: Shubhashisha Mohanty, et al.
Published: (2024-11-01)

Time to consider doxycycline in the standard treatment of lymphatic filariasis? Emerging evidence on use of doxycycline as an adjunct to hygiene protocols
by: Mian Zahid Jan Kakakhel, et al.
Published: (2025-03-01)

Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
by: M. A. Irvine, et al.
Published: (2015-10-01)

Evaluation of Mass Drug Administration Coverage for Lymphatic Filariasis in the Lukonga Health Zone in 2022
by: Patrick N. Ntumba, et al.
Published: (2024-07-01)

Molecular xenomonitoring as an indicator of microfilaraemia prevalence for lymphatic filariasis in Samoa in 2019
by: Maddison Howlett, et al.
Published: (2024-09-01)

Comparing different lymphatic filariasis patient estimate approaches and results in Ethiopia
by: Belete Mengistu, et al.
Published: (2024-02-01)